TCF3 and Burkitt lymphoma: Along with the expected mutation of the C-MYC proto-oncogene, additional recurrent mutations were observed in in the gene encoding TCF3 and that of its negative regulator ID3 with up to 70% of tumors bearing mutations in one or both of the genes suggesting TCF3 may play a vital role in BL lymphomagenesis.